Trial intelligence / Profile preview

Post-total thyroidectomy hypocalcemia after preoperative cholecalciferol supplementation

2024-516793-30-00Phase 3Completed

Sponsor
Hôpital NOVO
Start
Oct 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of Calcirol in hypocalcemia (2 arms), sponsored by Hôpital NOVO. Primary endpoint: Occurrence of serum and/or clinical hypocalcemia between surgery and day 15. Started Oct 2024; status: completed.

02

Drugs

Calcirol
03

Conditions

hypocalcemia

Beyond the preview

Go deeper on 2024-516793-30-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-516793-30-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call